Why the study?
Do beta-blockers and/or renin-angiotensin-aldosterone system inhibitors decrease blood pressure and improve arterial wall properties in patients with aortic disease?
Do beta-blockers and/or renin-angiotensin-aldosterone system inhibitors decrease blood pressure and improve arterial wall properties in patients with aortic disease?
Answers are grounded in this paper and cite their sources.
Beta-blockers and RAAS inhibitors are recommended as preferential antihypertensive therapy in patients with aortic disease to improve arterial wall properties.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Baguet et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: